ArticleOpen forum infectious diseases2019
The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant
Open access · goldAbstract read
In one paragraph
Article in Open forum infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 17 citations in OpenAlex.
- Restoration of β-lactam activity by nacubactam combinations against extensively drug-resistant K. pneumoniae harbouring diverse carbapenem resistance gene.World journal of microbiology & biotechnology · 2026Article
- Urinary Tract Infections Caused byMicroorganisms · 2025Article
- Ciprofloxacin for the Treatment of Infections Caused by Carbapenemase-Producing Gram-Negative Bacteria.Antibiotics (Basel, Switzerland) · 2024Article
- Trimethoprim-sulfamethoxazole as de-escalation in ventilator-associated pneumonia: a cohort study subanalysis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021Article
- Treating infections caused by carbapenemase-producing Enterobacterales (CPE): a pragmatic approach to antimicrobial stewardship on behalf of the UKCPA Pharmacy Infection Network (PIN).JAC-antimicrobial resistance · 2020Review
- Article
- How to manage KPC infections.Therapeutic advances in infectious diseaseReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 10 institutions in 1 country.
Courtney L LuterbachInstitute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina.
Ashley BosheInstitute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina.
Heather I HendersonInstitute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina.
Eric CoberDepartment of Infectious Diseases, Cleveland Clinic, Cleveland, Ohio.
Sandra S RichterDepartment of Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio.
Robert A SalataDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Robert C KalayjianDepartment of Medicine, MetroHealth Medical Center, Cleveland, Ohio.
Richard R WatkinsDepartment of Internal Medicine, Northeast Ohio Medical University, Rootstown, Ohio.
Andrea M HujerDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Kristine M HujerDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Susan D RudinDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio.
T Nicholas DomitrovicDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Yohei DoiDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Keith S KayeDivision of Infectious Diseases, University of Michigan, Ann Arbor, Michigan.
Scott EvansThe Biostatistics Center, The George Washington University, Rockville, Maryland.
Vance G FowlerDivision of Infectious Diseases, Duke University, Durham, North Carolina.
Robert A BonomoDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio.
David van DuinInstitute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina.ORCID 0000-0003-4784-3227
Louis Stokes Cleveland VA Medical Center · USUniversity of North Carolina at Chapel Hill · USCleveland Clinic · USCleveland Clinic Akron General · USDuke University · USGeorge Washington University · USMetroHealth · USUniversity of Michigan · USUniversity of Pittsburgh · USUniversity School · US
Funding
Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8MVirology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9MClinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0MUnderstanding B-Lactam Resistance in Acinetobacter baumanniiR01AI072219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI ROBERT A. BONOMO, Philip N. Rather · 2007 to 2026
$6.6MOptimizing Clinical Use of Polymyxin B: Teaching an Old Drug to Treat SuperbugsR01AI119446 · NIAID · WAYNE STATE UNIVERSITY · PI LI, JIAN, POGUE, JASON MICHAEL · 2015 to 2019
$5.0MUnderstanding ceftazidime resistance in SHV B-LactamasesR01AI063517 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A. · 2005 to 2023
$4.9MA Mechanism-Based Approach to Metallo-beta-Lactamase InhibitionR01AI100560 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A., SPENCER, JAMES · 2012 to 2022
$4.4MColistin-resistant Acinetobacter baumanniiR01AI104895 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI, ERNST, ROBERT K · 2014 to 2024
$4.2MMentoring Patient Oriented Research in Antibiotic-Resistant BacteriaK24AI093969 · NIAID · DUKE UNIVERSITY · PI FOWLER, VANCE G. · 2011 to 2020
$1.6MData commons for 'omic, microscopy and analysis core facilitiesS10OD018164 · OD · DUKE UNIVERSITY · PI WRAY, GREGORY A. · 2014 to 2014
$598kStudy Network of Acinetobacter as a Carbapenem-Resistant Pathogen (SNAP)R21AI135522 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI · 2018 to 2019
$460kMolecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniaeR21AI114508 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A., VAN DUIN, DAVID · 2015 to 2016
$445kBLRD VA I01 BX001974NCATS NIH HHS UL1 TR000439NIAID NIH HHS K24 AI093969NIAID NIH HHS P30 AI050410NIAID NIH HHS R01 AI063517NIAID NIH HHS R01 AI072219NIAID NIH HHS R01 AI100560NIAID NIH HHS R01 AI104895NIAID NIH HHS R01 AI119446NIAID NIH HHS R21 AI114508NIAID NIH HHS R21 AI123747NIAID NIH HHS R21 AI135522NIAID NIH HHS UM1 AI104681NIH HHS S10 OD018164
Abstract
In the Consortium on Resistance Against Carbapenems in
Indexed as
antimicrobial resistancecarbapenem-resistant EnterobacteriaceaeKlebsiella pneumoniatrimethoprim-sulfamethoxazoleurinary tract infection
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.